Last News

Canada Metabolic Disorder Market: New market analysis published PharmaPoint: Obesity - Canada Drug Forecast and Market Analysis to 2022 - a new market research report on companiesandmarkets.com PharmaPoint: Obesity - Canada Drug Forecast and Market Analysis to 2022. After a more than decade long dormancy, the Obesity market is undergoing a revival with the advent of several novel therapies that will lend considerable visibility to this indication space.
[more]
Japan Metabolic Disorder Market: New market analysis published PharmaPoint: Obesity - Japan Drug Forecast and Market Analysis to 2022 - a new market research report on companiesandmarkets.com PharmaPoint: Obesity - Japan Drug Forecast and Market Analysis to 2022. After a more than decade long dormancy, the Obesity market is undergoing a revival with the advent of several novel therapies that will lend considerable visibility to this indication space.
[more]
United Kingdom Metabolic Disorder Market: New market analysis published PharmaPoint: Obesity - UK Drug Forecast and Market Analysis to 2022 - a new market research report on companiesandmarkets.com PharmaPoint: Obesity - UK Drug Forecast and Market Analysis to 2022. After a more than decade long dormancy, the Obesity market is undergoing a revival with the advent of several novel therapies that will lend considerable visibility to this indication space.
[more]
Spain Metabolic Disorder Market: New market analysis published PharmaPoint: Obesity - Spain Drug Forecast and Market Analysis to 2022 - a new market research report on companiesandmarkets.com PharmaPoint: Obesity - Spain Drug Forecast and Market Analysis to 2022. After a more than decade long dormancy, the Obesity market is undergoing a revival with the advent of several novel therapies that will lend considerable visibility to this indication space.
[more]
Italy Metabolic Disorder Market: New market analysis published PharmaPoint: Obesity - Italy Drug Forecast and Market Analysis to 2022 - a new market research report on companiesandmarkets.com PharmaPoint: Obesity - Italy Drug Forecast and Market Analysis to 2022. After a more than decade long dormancy, the Obesity market is undergoing a revival with the advent of several novel therapies that will lend considerable visibility to this indication space.
[more]
Germany Metabolic Disorder Market: New market analysis published PharmaPoint: Obesity - Germany Drug Forecast and Market Analysis to 2022 - a new market research report on companiesandmarkets.com PharmaPoint: Obesity - Germany Drug Forecast and Market Analysis to 2022. After a more than decade long dormancy, the Obesity market is undergoing a revival with the advent of several novel therapies that will lend considerable visibility to this indication space.
[more]
France Metabolic Disorder Market: New market analysis published PharmaPoint: Obesity - France Drug Forecast and Market Analysis to 2022 - a new market research report on companiesandmarkets.com PharmaPoint: Obesity - France Drug Forecast and Market Analysis to 2022. After a more than decade long dormancy, the Obesity market is undergoing a revival with the advent of several novel therapies that will lend considerable visibility to this indication space.
[more]
United States Metabolic Disorder Market: New market analysis published PharmaPoint: Obesity - US Drug Forecast and Market Analysis to 2022 - a new market research report on companiesandmarkets.com PharmaPoint: Obesity - US Drug Forecast and Market Analysis to 2022. After a more than decade long dormancy, the Obesity market is undergoing a revival with the advent of several novel therapies that will lend considerable visibility to this indication space.
[more]
Systemic lupus erythematosus drug sales to total US$473.6Mn in 2012 across the seven major markets PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2022 - a new market research report on companiesandmarkets.com Sales for SLE and LN by Region, 2012–2022. Analysts estimate 2012 Systemic Lupus Erythematosus (SLE) drug sales to be over $473.6m across the seven major markets covered in this report: US, France, Germany, Italy, Spain, UK
[more]
Obesity therapy market forecast to be valued at US$8.4Bn by 2022 PharmaPoint: Obesity - Global Drug Forecast and Market Analysis to 2022 - a new market research report on companiesandmarkets.com Obesity therapy market is forecast to reach a value of US$8.4 billion by 2022. Due to the launches of several novel drugs during the next decade, the obesity market will increase from $407m in 2012 to $8.4 billion by 2022, at
[more]
Global hemophilia market driven by the uptake of premium priced, long-acting recombinant treatments PharmaPoint: Hemophilia A and B - Global Drug Forecast and Market Analysis to 2022 - a new market research report on companiesandmarkets.com Emerging Therapies to Seize Half of Hemophilia Market Share by 2018, Changing Landscape. The recombinant hemophilia market is set to change drastically over the next four years, with emerging long-acting treatments expected to take over half of the
[more]
Global atopic dermatitis market growth fueled by new product launches PharmaPoint: Atopic Dermatitis - Global Drug Forecast and Market Analysis to 2022 - a new market research report on companiesandmarkets.com Global Atopic Dermatitis Market to Grow Slightly by 2022, Fueled by New Product Launches. The atopic dermatitis therapeutic sales in the nine major markets (9MM) — the US, France Germany, Italy, Spain, UK, Japan, China and India — are forecast
[more]
Global MCD pharmaceutical market in the seven major markets totalled US$3.6Bn in 2012 PharmaPoint: Microvascular Complications of Diabetes - Global Drug Forecast and Market Analysis to 2022 - a new market research report on companiesandmarkets.com The 7 major markets (US, France, Germany, Italy, Spain, UK, and Japan) MCD pharmaceutical market in the 2012 base year was $3.6 billion, including both branded and generic drugs. At 51% of the overall MCD market, the US
[more]
Global Immunology Market: New industry data available Vercirnon (Crohn’s Disease) - Forecast and Market Analysis to 2022 - a new market research report on companiesandmarkets.com Vercirnon (Crohn´s Disease) - Forecast and Market Analysis to 2022. The Crohn´s disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon. These compounds will challenge the current biologics in an attempt to dislodge the stronghold of the
[more]
Global Immunology Market: New industry data available Tysabri (Crohn’s Disease) - Forecast and Market Analysis to 2022 - a new market research report on companiesandmarkets.com Tysabri (Crohn´s Disease) - Forecast and Market Analysis to 2022. The Crohn´s disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon. These compounds will challenge the current biologics in an attempt to dislodge the stronghold of the
[more]
Global Immunology Market: New industry data available Stelara (Crohn’s Disease) - Forecast and Market Analysis to 2022 - a new market research report on companiesandmarkets.com Stelara (Crohn´s Disease) - Forecast and Market Analysis to 2022. The Crohn´s disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon. These compounds will challenge the current biologics in an attempt to dislodge the stronghold of the
[more]
Global Immunology Market: New industry data available Remicade (Crohn’s Disease) - Forecast and Market Analysis to 2022 - a new market research report on companiesandmarkets.com Remicade (Crohn´s Disease) - Forecast and Market Analysis to 2022. The Crohn´s disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon. These compounds will challenge the current biologics in an attempt to dislodge the stronghold of the
[more]
Global Immunology Market: New industry data available Prochymal (Crohn’s Disease) - Forecast and Market Analysis to 2022 - a new market research report on companiesandmarkets.com Prochymal (Crohn´s Disease) - Forecast and Market Analysis to 2022. The Crohn´s disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon. These compounds will challenge the current biologics in an attempt to dislodge the stronghold of the
[more]
Global Immunology Market: New industry data available Humira (Crohn’s Disease) - Forecast and Market Analysis to 2022 - a new market research report on companiesandmarkets.com Humira (Crohn´s Disease) - Forecast and Market Analysis to 2022. The Crohn´s disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon. These compounds will challenge the current biologics in an attempt to dislodge the stronghold of the
[more]
Global Immunology Market: New industry data available Entyvio (Crohn’s Disease) - Forecast and Market Analysis to 2022 - a new market research report on companiesandmarkets.com Entyvio (Crohn´s Disease) - Forecast and Market Analysis to 2022. The Crohn´s disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon. These compounds will challenge the current biologics in an attempt to dislodge the stronghold of the
[more]

Search Live-PR

Live-PR Services